Cargando…
Signaling pathways and targeted therapy for myocardial infarction
Although the treatment of myocardial infarction (MI) has improved considerably, it is still a worldwide disease with high morbidity and high mortality. Whilst there is still a long way to go for discovering ideal treatments, therapeutic strategies committed to cardioprotection and cardiac repair fol...
Autores principales: | Zhang, Qing, Wang, Lu, Wang, Shiqi, Cheng, Hongxin, Xu, Lin, Pei, Gaiqin, Wang, Yang, Fu, Chenying, Jiang, Yangfu, He, Chengqi, Wei, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913803/ https://www.ncbi.nlm.nih.gov/pubmed/35273164 http://dx.doi.org/10.1038/s41392-022-00925-z |
Ejemplares similares
-
The Networks of Noncoding RNAs and Their Direct Molecular Targets in Myocardial Infarction
por: Wang, Shiqi, et al.
Publicado: (2022) -
MiR-125 Family in Cardiovascular and Cerebrovascular Diseases
por: Wang, Yang, et al.
Publicado: (2021) -
CD44 promotes angiogenesis in myocardial infarction through regulating plasma exosome uptake and further enhancing FGFR2 signaling transduction
por: Zhang, Qing, et al.
Publicado: (2022) -
Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases
por: Pei, Gaiqin, et al.
Publicado: (2023) -
Role of miR-182 in cardiovascular and cerebrovascular diseases
por: Pei, Gaiqin, et al.
Publicado: (2023)